Depression and Anxiety Trial, Recruiting NCT07324070 Sponsor: Charles University, Czech Republic Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07324070
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You must have a score of 20 or higher on a standard depression rating scale called the MADRS, which measures how severe your depression is (confirm with trial site)
  • You must have been diagnosed with Major Depressive Disorder according to recognised medical guidelines (ICD-10)

Who may not be able to join:

  • You have been diagnosed with another major mental health condition, such as schizophrenia or addiction
  • You have been diagnosed with dementia
  • You have received ECT (electroconvulsive therapy, a brain stimulation treatment) in the last 3 months
  • You have received TMS (transcranial magnetic stimulation, another type of brain stimulation treatment) in the last 3 months
  • You have a psychotic illness or are currently experiencing psychotic symptoms, such as hallucinations or delusions
  • You are currently pregnant or breastfeeding
  • You have been diagnosed with a neurological condition, such as epilepsy
  • You have taken part in another clinical trial within the last 30 days
  • You have a physical health condition that means ECT treatment would not be safe for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Charles University, Czech Republic
Registry
ClinicalTrials.gov
Start date
5 January 2026
Est. completion
5 January 2028

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

reduction of the seizure treshold of ECT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov